2.1PatientSelection SelectpatientsforsecondlineorgreatertreatmentofmetastaticNSCLCwithKEYTRUDAbasedonthe presenceofpositivePD-L1expression[seeClinicalStudies(14.2)].InformationonFDA-approvedtests forthedetectionofPD-L1expressioninNSCLCisavailableat: . 2.2RecommendedDosing TherecommendeddoseofKEYTRUDAis2mg/kgadministered...
Melanoma Hepatitis (including autoimmune hepatitis) occurred in 2 (0.5%) of 411 patients, including a Grade 4 case in 1 (0.2%) patient, receiving KEYTRUDA in Trial 1. The time to onset was 22 days for the case of Grade 4 hepatitis which lasted 1.1 months. The patient with Grade 4 ...
Patient supportthroughout your treatment Patients who have been prescribed KEYTRUDA for an approved indication can access additional support from KEY+YOU, the patient support program for KEYTRUDA. KEY+YOU helps eligible patients by offering educational resources and support information throughout treatment....
Learn about KEYTRUDA® (pembrolizumab), an immunotherapy that works with your immune system to help fight certain cancers. Visit the patient website.
2 DOSAGE AND ADMINISTRATION 2.1 Patient Selection Select patients for second line or greater treatment of metastatic NSCLC with KEYTRUDA based on the presence of positive PD-L1 expression [see Clinical Studies (14.2)]. Information on FDA-approved tests for the detection of PD-L1 expression in ...
Patients who have been prescribed KEYTRUDA for an approved indication can access additional support from KEY+YOU, the patient support program for KEYTRUDA. KEY+YOU helps eligible patients by offering educational resources and support information throughout treatment.Call 85-KEYTRUDA (855-398-7832) Addit...
Patient Information/Medication Guide for KEYTRUDA at http://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_mg.pdf . MerckMedia:Pamela Eisele, 267-305-3558Courtney Ronaldo, 908-236-1108orInvestors:Teri Loxam...
Merck and Eisai announced today that KEYTRUDA®, an anti-PD-1 therapy, in combination with LENVIMA with respective clinical criteria and conditions for adult patients with advanced (not amenable to curative surge...
Patient Information/Medication Guide for KEYTRUDA (pembrolizumab) at https://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_mg.pdf . For MerckMedia:Pamela Eisele, 267-305-3558orElizabeth Sell, 267-305-3877orInvestors:Teri Loxam, 908-740-1986orMichael DeCarbo, ...
“Patients with metastatic nonsquamous non-small cell lung cancer in China now have a new option for the first-line treatment of their disease, and we will continue to collaborate with the Chinese government, healthcare organizati...